Detalles de la búsqueda
1.
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.
Breast Cancer Res;
22(1): 1, 2019 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892325
2.
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.
Lancet Oncol;
17(5): 600-11, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27032301
3.
A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.
Breast Cancer Res Treat;
152(3): 569-80, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26160250
4.
Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.
Gynecol Oncol;
138(3): 663-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26142884
5.
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).
Lancet Oncol;
15(3): 267-74, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24508104
6.
Decrease social inequalities return-to-work: development and design of a randomised controlled trial among women with breast cancer.
BMC Cancer;
14: 267, 2014 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24742314
7.
CSF CA 15-3 in breast cancer-related leptomeningeal metastases.
J Neurooncol;
117(1): 117-24, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24469852
8.
Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
Anticancer Drugs;
24(10): 1093-7, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23962903
9.
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course.
Breast Cancer Res Treat;
131(2): 517-25, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22037787
10.
Predictors for establishing recommended phase 2 doses: analysis of 320 dose-seeking oncology phase 1 trials.
Invest New Drugs;
30(2): 653-61, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21049280
11.
Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis.
BMC Clin Pathol;
12: 21, 2012 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23145812
12.
Nature and subjectivity of dose-limiting toxicities in contemporary phase 1 trials: comparison of cytotoxic versus non-cytotoxic drugs.
Invest New Drugs;
29(6): 1414-9, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20617363
13.
Clinicopathological features of breast cancers predict the development of leptomeningeal metastases: a case-control study.
J Neurooncol;
105(2): 309-15, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21547396
14.
Securing the circuit of intrathecally administered cancer drugs: example of a collective approach.
J Oncol Pharm Pract;
17(3): 252-9, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20525750
15.
Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures.
Breast Cancer Res Treat;
121(1): 23-33, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19565332
16.
Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trials.
Invest New Drugs;
28(6): 839-43, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19756372
17.
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics.
Invest New Drugs;
28(1): 76-82, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19205623
18.
Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.
Oncology;
78(2): 87-93, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20357516
19.
Is there a reliable method to assess the complete pathologic response on the tumor after neo-adjuvant chemotherapy in inflammatory breast cancer toward recommendations for the pathologic process? Experience in 56 patients treated in a single institution.
Breast J;
16(5): 464-71, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20722651
20.
Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.
Neuro Oncol;
22(4): 524-538, 2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31637444